Amount Raised
$2.4 Million
Round Type
Convertible Note
HendersonBiotechnologyHealth CareGeneticsTherapeuticsHealth DiagnosticsInvestors
Description
VolitionRx Limited has entered into a Securities Purchase Agreement with Lind Global Asset Management, resulting in the issuance of a senior secured convertible promissory note worth $2,400,000. The Company made a partial prepayment of $500,000 towards the outstanding balance of the note. Additionally, an agreement has been reached that defers required repayments for November and December 2026.
Quick answer
VolitionRx raised $2.4 Million in a Convertible Note round, dated October 27, 2026. Investors: Lind Global Asset Management XII LLC. VolitionRx is based in Henderson, Nevada, United States.
- How much did VolitionRx raise?
- VolitionRx raised $2.4 Million in a Convertible Note round on October 27, 2026.
- Who invested in VolitionRx?
- Lind Global Asset Management XII LLC is named as investors in this round.
- What does VolitionRx do?
- VolitionRx Limited is a multi-national epigenetics company dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment..
- Where is VolitionRx based and how big is it?
- VolitionRx is based in Henderson, Nevada, United States. Fundz records about 86 employees.
- Who are the decision-makers at VolitionRx?
- Fundz holds 5 contacts at VolitionRx, including the Group Chief Marketing & Communications Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as VolitionRx that raised within 45 days of this round, from Fundz verified event records.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- Estuary Biotherapeutics raised $93M (Series A) on October 16, 2026.
- Float Bio raised $140K (Pre-Seed) on October 15, 2026.
- seragy holding GmbH raised $13M on October 14, 2026.
- Arboretum LifeSciences raised $30M (Series A) on October 7, 2026.
- Aptadir Therapeutics raised $45M (Seed) on September 29, 2026.
Who to call at VolitionRx, and when
A new round usually means VolitionRx is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day VolitionRx raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at VolitionRx, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at VolitionRx. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment VolitionRx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
VolitionRx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.